Extracts and distillates
Our extracts, distillates and premixes come from organically grown flowers and produced under GACP growing standards. The power profile, stability, terpenes profile and characteristics of our oils and raw materials are obtained by super-cryptic CO2 technology, and cryogenic ethanol that allow the manufacture of finished products and medicines of the best quality.
|
86% CBD broad spectrum extract: CBD: 86%+-4%. THC: <0.2% |
|
70% CBD broad spectrum extract: CBD:70%+-4%. THC: <0.2% |
|
30% CBD broad spectrum extract: CBD:30%+-3%. THC: <0.2%. Tailor made potency available. |
|
15% CBD broad spectrum extract: CBD:15%+-3%. THC: <0.2%. Additional terpenes added. Tailor made potency available |
|
40% CBD full spectrum extract: CBD:40%+-2%. THC: <0.7% |
|
20% CBD full spectrum extract: CBD:20%+-2%. THC: <0.3% |
|
80% THC Full spectrum extract: THC: 80%+-4%. CBD: 5% |
|
65% THC Full spectrum crude extract: THC: 65%+-3%. CBD: 4% |
|
30% THC Full spectrum extract: THC: 30%+-2%. CBD: 2% |
Extracts and distillates of organically grown flower, under EU-GACP standards. They meet European pharmacopeia quality limits in all their test certificates: heavy metals, aflatoxins, microbiologics, residual solvents, cannabinoid potency and terpenes.
Value proposition
Family business with
decades of experience
We have decades of international experience in high quality crops on a large scale, and in the development and distribution of pharmaceuticals.
High performance
registered genetics
High performance certified strains and stabilized genetics of both psychoactive and non-psychoactive quality.
Pharmaceutical
growing model
The rigorousness, traceability and stability of our organic and hydroponic production model takes us a step further on quality issues, standards that reflect our identity and define our purpose.
R&D&I model
Research, development and innovation are in our DNA, from genetics to the final product.
Subscribe to our newsletter
Sign up for monthly industry and company news